Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot study

被引：18

作者：

Hagens, Marloes H. J. ^{[1
,2
]}

Killestein, Joep ^{[1
,2
]}

Yaqub, Maqsood M. ^{[3
]}

van Dongen, Guus A. M. S. ^{[3
]}

Lammertsma, Adriaan A. ^{[3
]}

Barkhof, Frederik ^{[2
,3
]}

van Berckel, Bart N. M. ^{[2
,3
]}

机构：

[1] Vrije Univ Amsterdam Med Ctr, Dept Neurol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands

[2] Vrije Univ Amsterdam Med Ctr, MS Ctr Amsterdam, Amsterdam, Netherlands

[3] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands

来源：

MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷 / 04期

关键词：

Multiple sclerosis; rituximab; monoclonal antibodies; B-lymphocytes; positron emission tomography; magnetic resonance imaging; IMMUNO-PET;

D O I：

10.1177/1352458517704507

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Previous studies have demonstrated that the chimeric monoclonal antibody rituximab significantly reduces clinical and radiological disease activity in relapsing-remitting multiple sclerosis as early as 4weeks after the first administration. The exact mechanisms leading to this rapid effect have not yet been clarified. The aim of this positron emission tomography study was to assess central nervous system penetration as a possible explanation, using zirconium-89-labelled rituximab. No evidence was found for cerebral penetration of [Zr-89]rituximab.

引用

页码：543 / 545

页数：3

共 50 条

[21] Headache in multiple sclerosis - pilot study
Dolezil, D
Hradilek, P
Zapletalova, O
Mrazkova, M
Jezkova, I
CEPHALALGIA, 2005, 25 (08) : 656 - 656
[22] A pilot study of pentoxifylline in multiple sclerosis
Friedman, JE
Zabriskie, J
Bourganskaia, E
ARCHIVES OF NEUROLOGY, 1996, 53 (10) : 956 - 957
[23] Sleepiness in multiple sclerosis: A pilot study
Beran, Roy G.
Ainley, Laetitia Ae
Holland, Gerard
SLEEP AND BIOLOGICAL RHYTHMS, 2008, 6 (04) : 194 - 200
[24] The Efficacy of Rituximab in Systemic Sclerosis Joint Disease: A Pilot Study
Borrell Panos, Helena
Narvaez, Javier
Jose Alegre, Juan
Castellvi, Ivan
Albert Espi, Gloria
Heredia, Sergi
Toniolo, Elide
Miquel Nolla, Joan
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[25] Altered splenic [89Zr]Zr-rituximab uptake in patients with interstitial lung disease not responding to rituximab: could this indicate a splenic immune-mediated mechanism?
Adams, Human
Meek, Bob
van de Garde, Ewoudt M. W.
van Moorsel, Coline H. M.
Vugts, Danielle J.
Keijsers, Ruth G.
Grutters, Jan C.
AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 10 (04): : 168 - +
[26] Preclinical development of [89Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas
Alvarez, Natalia Herrero
Lewis, Jason
NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S192 - S193
[27] Fatigue and sleepiness in multiple sclerosis: Pilot study
Beran, R
Ainley, LAE
Holland, G
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S221 - S221
[28] A pilot study of valacyclovir in the treatment of multiple sclerosis
Friedman, JE
Zabriskie, JB
Plank, C
Ablashi, D
Whitman, J
NEUROLOGY, 2001, 56 (08) : A352 - A352
[29] Autoimmune retinopathy in multiple sclerosis: A pilot study
Sproule, M
Forooghian, F
O'Connor, P
Gordon, L
Jirawuthiworavong, G
Wastall, C
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U585 - U585
[30] Pilot study: Fatigue, sleep & multiple sclerosis
Beran, RG
Ainley, LA
Holland, GJ
NEUROLOGY, 2005, 64 (06) : A387 - A387

← 1 2 3 4 5 →